z-logo
open-access-imgOpen Access
Aberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator
Author(s) -
Tania Gourley,
Dipak R. Patel,
Kevin M. Nickerson,
Soon–Cheol Hong,
CheongHee Chang
Publication year - 2002
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.168.9.4414
Subject(s) - ciita , fas ligand , mhc class ii , biology , effector , major histocompatibility complex , transactivation , microbiology and biotechnology , ligand (biochemistry) , mhc class i , apoptosis , cancer research , chemistry , immune system , immunology , gene expression , gene , receptor , genetics , programmed cell death
The MHC class II transactivator (CIITA) is a critical regulator of MHC class II genes and other genes involved in the Ag presentation pathway. CIITA-deficient mice lack MHC class II expression on almost all APCs. In this study, we show that these mice also have aberrant Fas ligand expression on both CD4 T cells and B cells. We found that Fas ligand expression was greatly increased on CIITA-deficient CD4 T cells during the Th1 differentiation process. However, both CIITA-deficient and control Th1 effector cells up-regulated Fas ligand to similar levels if cells were reactivated. The introduction of CIITA into primary CD4 T cells via retroviral infection resulted in a reduction in the level of Fas ligand and delay in apoptosis after activation. Interestingly, activated B cells from the CIITA-deficient mice also showed increased levels of Fas ligand that could be to some degree inhibited by the introduction of IL-4.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom